TGFB2 and neoplasm: In parallel to the association with TGFB pathway activation observed in this study, our list included TGFB2 which is considered to be a link between epithelial–mesenchymal transition (EMT) and tumor mutation burden in gastric cancer, and its high expression was associated with poor prognosis in multiple datasets [58].